![]() ![]() (2015) 6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumor growth by inhibiting LKB1-AMPK signaling. Lin, R.*, Elf, S.*, Shan, C.*, Kang, H., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J.-H., Xie, J., Tucker, M., Gu, T.-L., Sudderth, J., Jiang, L., Mitsche, M., DeBerardinis, R., Wu, S., Li, Y., Mao, H., Chen, P., Wang, D., Chen, Z., Hurwitz, S., Lonial, S., Arellano, M., Khoury, H., Khuri, F., Lee, L., Lei, Q., Brat, D., Ye, K., Boggon, T., He, C., Kang, S., Fan, J.,and Chen, J. (2016) Tetrameric acetyl-CoA acetyltransferase 1 is important for tumor growth. J., Zhang, G., Owonikoko, T., Gaddh, M., Arellano, M.L., Khoury, H.J., Khuri, F.R., Kang, S., Doetsch, P.W., Lonial, S., Boggon, T.J., Curran, W. Highlighted by Natureįan, J.*, Lin, R.*, Xia, S., Chen, D., Elf, S.E., Liu, S., Pan, Y., Xu, H., Qian, Z., Wang, M., Shan, C., Zhou, L., Lei, Q.-Y., Li, Y., Mao, H., Lee, B.H., Sudderth, J., DeBerardinis, R. Cell Metabolism Volume 25, Issue 2, 7 February 2017, Pages 358–373. ![]() (2017) Prevention of dietary fat-fueled ketogenesis attenuates BRAF V600E tumor growth. Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H.-B., Pan, Y., Liu, S., Qian, G., Qian, Z., Konstantakou, E., Zhang, B., Dong, J.-T., Chung, Y., Abdel-Wahab, O., Merghoub, T., Zhou, L., Kudchadkar, R.R., Lawson, D.H., Khoury, H.J., Khuri, F.R., Boise, L.H., Lonial, S., Lee, B.H., Pollack, B.P., Arbiser, J.L., Fan, J., Lei, Q.-Y., and Chen, J. Molecular Cell 69, 923–937, Ma(Featured article). (2018) Dietary supplement chondroitin-4-sulfate exhibits oncogene-specific pro-tumor effects on BRAF V600E melanoma cells. ![]() Lin, R., Xia, S., Shan, C., Chen, D., Liu, Y., Gao, X., Wang, M., Kang, H.-B., Pan, Y., Liu, S., Chung, Y., Abdel-Wahab, O., Merghoub, T., Rossi, M., Kudchadkar, R.R., Lawson, D.H., Khuri, F.R., Lonial, S., and Chen, J. Ĭhen, D.*, Xia, S.*, Wang, M.*, Lin, R., Li, Y., Mao, H., Aguiar, M., Famulare, C., Shih, A.H., Brennan, C.W., Gao, X., Pan, Y., Liu, S., Fan, J., Jin, L., Song, L., Zhou, A., Mukherjee, M., Pieper, R.O., Mishra, A., Peng, J., Arellano, M., Blum, W., Lonial, S., Boggon, T.J., Levine, R.L.#, and Chen, J.# (2019) Mutant and wild-type IDH1 share enhancing mechanisms involving distinct tyrosine kinase cascades in cancer. (2019) gamma-6-phosphogluconolactone, a byproduct of the oxidative pentose phosphate pathway, contributes to AMPK activation through inhibition of PP2A. Gao, X.*, Zhao, L.*, Liu, S.*, Li, Y., Xia, S., Chen, D., Wang, M., Wu, S., Dai, Q., Cai, F., Zacharias, L., DeBerardinis, R., Lim, E., Metallo, C., Boggon, T.J., Lonial, S., Lin, R., Mao, H., Pan, Y., Shang, C., and Chen, J. # (2021) Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. # (2022) Cellular signals converge at the NOX2-SHP-2 axis to induce reductive carboxylation in cancer cells. # (2022) Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation. #, Liu, Y., Li, Y., Fan, H., Wu, R., Zhang, R., Faubert, B., He, Y.-Y., Bissonnette, M.B., Xia, S., Chen, D., Mao, H., Boggon, T.J., and Chen, J. # (2023) Trans-vaccenic acid reprograms CD8 + T cells and anti-tumor immunity. Fan, H., * Xia, S., * Xiang, J., * Li, Y., Ross, M.O., Lim, S.A., Yang, F., Tu, J., Xie, L., Dougherty, U., Zhang, F.Q., Zheng, Z., Zhang, R., Wu, R., Dong, L., Su, R., Chen, X., Althaus, T., Riedell, P.A., Jonker, P.B., Muir, A., Lesinski, G.B., Rafiq, S., Dhodapkar, M.V., Stock, W., Odenike, O., Patel, A.A., Opferman, J., Tsuji, T., Matsuzaki, J., Shah, H., Faubert, B., Elf, S.E., Layden, B., Bissonnette, B.M., He, Y.-Y., Kline, J., Mao, H., Odunsi, K., Gao, X., Chi, H., # He, C., # and Chen, J. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |